Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

"Cumulative incidence of toxicity between 2 and 5 years following SBRT to the prostate and pelvis nodes in patients with high-risk prostate cancer ".

Practical radiation oncology·2026
Same author

The Ki-67 proliferation index and recurrence risk of intracranial meningioma: a multicenter, retrospective cohort study of 5,050 patients.

Acta neurochirurgica·2026
Same author

Prediction Analysis of Microarray of 50 genes (PAM50) classifier validated for predicting prostate cancer progression in active surveillance: Miami Active Surveillance Trial (MAST).

BJU international·2026
Same author

Re: Riccardo Bertolo, Antonio Luigi Pastore, Paolo Verze, et al. Real-World Burden and Management of Late Genitourinary Toxicity After Prostate Radiotherapy: Insights from IRRADIaTE, the Italian Registry of Radiotherapy-Associated Disorders and Urological Treatment & Evaluation. Eur Urol Oncol. 2026;9:408-416. https://doi.org/10.1016/j.euo.2026.01.005.

European urology oncology·2026
Same author

Fractionated radiotherapy adjuvant to surgery of WHO-2 meningioma with and without gross total resection: a multicenter, retrospective cohort study of 1,452 patients.

Journal of neuro-oncology·2026
Same author

MRI-based patient selection for active surveillance in prostate cancer using U-Found: a generalized deep learning model.

Cancer imaging : the official publication of the International Cancer Imaging Society·2026

Related Experiment Video

Updated: Mar 22, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

21.2K

Prostate cancer radiation therapy: A physician's perspective.

Alan Dal Pra1, Luis Souhami2

  • 1Department of Radiation Oncology, Bern University Hospital, Bern, Switzerland.

Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)
|April 9, 2016
PubMed
Summary

Radiotherapy, including advanced techniques and androgen deprivation therapy, has significantly improved prostate cancer treatment outcomes. Ongoing research aims to further personalize care through biomarkers and evolving technologies for better patient benefit.

Keywords:
3-D radiotherapyIMRTImage-guided radiotherapyProstate cancerRadiotherapy

More Related Videos

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.8K
Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

2.1K

Related Experiment Videos

Last Updated: Mar 22, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

21.2K
Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.8K
Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

2.1K

Area of Science:

  • Oncology
  • Radiation Oncology
  • Urologic Oncology

Background:

  • Prostate cancer is a leading cause of cancer death in men globally.
  • Ionizing radiation is a cornerstone in curative treatment strategies for prostate cancer.
  • Advancements in radiotherapy have enhanced precision and therapeutic ratios.

Purpose of the Study:

  • To provide an overview of radiotherapy for localized prostate cancer from a clinical perspective.
  • To discuss the evolution and current status of prostate cancer radiotherapy techniques.
  • To highlight the role of androgen deprivation therapy and dose escalation in treatment.

Main Methods:

  • Review of historical evolution of radiotherapy techniques: 3D-conformal radiotherapy (3D-CRT), intensity-modulated radiotherapy (IMRT), and image-guided radiotherapy (IGRT).
  • Integration of androgen deprivation therapy (ADT) in treatment protocols.
  • Analysis of evidence from randomized controlled trials on dose escalation and hypofractionated radiotherapy (RT).

Main Results:

  • Radiotherapy evolution has led to more accurate and precise cancer treatments.
  • Combined androgen deprivation therapy significantly improves overall survival for intermediate- and high-risk prostate cancer.
  • Dose escalation and hypofractionated RT demonstrate improved local control with proven efficacy and safety.

Conclusions:

  • Significant progress has been made in prostate cancer radiotherapy, but open questions remain.
  • Individualized treatment approaches using prognostic and predictive biomarkers are essential.
  • Critical evaluation of new technologies, balancing costs and clinical benefits, is necessary for optimal patient care.